US equities |
MU $1,088.00 ▲+0.00% SNDK $1,692.42 ▲+0.00% NVDA $237.47 ▲+0.00% INTC $113.12 ▲+0.00% PLTR $194.12 ▲+0.00% AMD $645.86 ▲+0.00% MSTR $153.37 ▲+0.00% SPCX $167.60 ▲+0.00%
FinancialContent

Latest News about NASDAQ:RNXT

Recent news which mentions NASDAQ:RNXT

RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024
Tickers RNXT
Tags Earnings Reports Market News RNXT
From InvestorPlace
RNXT Stock Earnings: RenovoRx Beats EPS for Q1 2024
Tickers RNXT
Tags RNXT NASDAQ:RNXT Earnings Reports
From InvestorPlace
RNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023
Tickers RNXT
Tags Market News Earnings Reports NASDAQ:RNXT
From InvestorPlace
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
Tickers IMU RNXT
Tags NASDAQ:RNXT
From News Direct
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
Tickers RNXT
Tags NASDAQ:RNXT
From News Direct
RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube
Tags NASDAQ:RNXT
From News Direct
RenovoRX's Latest Innovative Technology Creates New Hope For Chemotherapy Patients
Tags NASDAQ:RNXT
From News Direct